Quick Answer
Caribou Biosciences, Inc. reported Net Income Loss of -$148.13 million for the year ending 2025.
- Caribou Biosciences, Inc. showed an increase of +0.7% in Net Income Loss from 2024 to 2025.
- This data is from Caribou Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Caribou Biosciences, Inc.'s Net Income Loss has declined by 532.2%.
- Historical annual values: Fiscal year 2025: -$148.13 million | Fiscal year 2024: -$149.11 million | Fiscal year 2023: -$102.07 million | Fiscal year 2022: -$99.42 million | Fiscal year 2021: -$66.92 million | Fiscal year 2020: -$34.31 million | Fiscal year 2019: -$23.43 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: